-
EP4272828
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4272828
| EP4272828 - ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.07.2024 Database last updated on 03.09.2024 | |
| Former | The application has been published Status updated on 06.10.2023 | Most recent event Tooltip | 01.08.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | [2023/45] | Inventor(s) | 01 /
DEMATTOS, Ronald Bradley Indianapolis, 46285 / US | 02 /
IRIZARRY, Michael Carl Indianapolis, 46285 / US | [2023/45] | Representative(s) | Boanas-Evans, Duncan Richard, et al Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | [N/P] |
| Former [2023/45] | Kent, Lindsey Ruth, et al Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | Application number, filing date | 23176986.0 | 23.06.2017 | [2023/45] | Priority number, date | US201662357579P | 01.07.2016 Original published format: US 201662357579 P | [2023/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4272828 | Date: | 08.11.2023 | Language: | EN | [2023/45] | Type: | A3 Search report | No.: | EP4272828 | Date: | 10.01.2024 | Language: | EN | [2024/02] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.12.2023 | Classification | IPC: | C07K16/18, A61K39/395, A61P25/28 | [2024/02] | CPC: |
C07K16/18 (EP,CN,EA,IL,KR,US);
A61K39/3955 (IL,US);
A61P25/00 (EP,IL);
A61P25/28 (EP,CN,IL,KR,US);
A61P43/00 (EP);
A61K2039/505 (CN,IL,KR);
A61K2039/507 (EP,EA);
A61K2039/545 (CN,IL,US);
C07K2317/24 (CN,US);
C07K2317/51 (CN);
C07K2317/515 (CN,IL);
C07K2317/56 (CN,IL);
|
| Former IPC [2023/45] | A61P25/28 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/33] |
| Former [2023/45] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 10.07.2024 | ME | 10.07.2024 | Validation states | MA | 10.07.2024 | MD | 10.07.2024 | Title | German: | ANTI-N3PGLU AMYLOID BETA PEPTID ANTIKÖRPER UND DEREN VERWENDUNG | [2023/45] | English: | ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | [2023/45] | French: | ANTICORPS ANTI-PEPTIDE BÊTA-AMYLOÏDE N3PGLU ET LEURS UTILISATIONS | [2023/45] | Examination procedure | 10.07.2024 | Examination requested [2024/33] | 10.07.2024 | Date on which the examining division has become responsible | 31.07.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | Parent application(s) Tooltip | EP17736841.2 / EP3478712 | Fees paid | Renewal fee | 02.10.2023 | Renewal fee patent year 03 | 02.10.2023 | Renewal fee patent year 04 | 02.10.2023 | Renewal fee patent year 05 | 02.10.2023 | Renewal fee patent year 06 | 02.10.2023 | Renewal fee patent year 07 | 01.07.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY]WO2012021469 (LILLY CO ELI [US], et al); | [A]WO2015175769 (BIOGEN MA INC [US]); | [IY]WO2016043997 (LILLY CO ELI [US]); | by applicant | US7195761 | WO2007068429 | WO2010009987 | US8025878 | US8066999 | WO2011151076 | WO2012136552 | US8679498 | US8729071 | WO2014089500 | US8841293 | WO2016043996 | WO2016053767 | US20080521309 | WO2016US14423 |